Athersys (ATHX) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. PTC
5. ATH
6. TSLA
7. CME
8. USO
9. AMD
10. EVTL

Go back to Athersys (ATHX) Misses Q3 EPS by 2c

Athersys Reports Third Quarter 2020 Results and Provides Corporate Update

November 9, 2020 4:05 PM EST

Company announces initiation of MultiStem® Phase 2 study led by UTHealth in patients with trauma related inflammation and complications at Memorial Hermann-Texas Medical Center

Management to host conference call at 4:30 pm EST today

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended September 30, 2020 and provided a corporate update.

Highlights of the third quarter of 2020 and recent events include:

Received Regenerative Medicine Advanced Therapy (RMAT) designation for MultiStem®... More